Catalent

Catalyst + Talent. Our name combines these ideas. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. With over 80 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance and provide superior, reliable manufacturing and packaging results.
Catalent develops. With our broad range of expert services we drive faster, more efficient development timelines to help you take more molecules to market and create more effective products.
Catalent delivers. As the world leader in drug delivery innovations, we have a proven record of enhancing bioavailability, solubility and permeability, improving ease and route of administration, and increasing patient compliance for better treatments.
Catalent supplies. Globally positioned to serve all your manufacturing and commercial packaging needs, we provide integrated solutions to take your product from design, to clinical trial, to plant, and to pharmacy.
Catalent. More products. Better treatments. Reliably supplied.™

Company Growth (employees)
Type
Public
HQ
Franklin Township, US
Founded
2007
Size (employees)
9,200 (est)
Catalent was founded in 2007 and is headquartered in Franklin Township, US

Catalent Office Locations

Catalent has offices in Franklin Township, Braeside, Jiaxing, Kakegawa and in 28 other locations
Franklin Township, US (HQ)
14 Schoolhouse Rd
Show all (32)

Catalent Data and Metrics

Catalent Financial Metrics

Catalent's revenue was reported to be $532.6 m in Q3, 2017
USD

Revenue (Q3, 2017)

532.6 m

Gross profit (Q3, 2017)

167.4 m

Gross profit margin (Q3, 2017), %

31%

Net income (Q3, 2017)

26 m

EBIT (Q3, 2017)

64.6 m

Market capitalization (22-Sep-2017)

5.1 b

Cash (31-Mar-2017)

241.2 m
Catalent's current market capitalization is $5.1 b.
USDFY, 2014FY, 2015FY, 2016

Revenue

1.8 b1.8 b1.8 b

Revenue growth, %

0%1%

Cost of goods sold

1.2 b1.2 b1.3 b

Gross profit

598.6 m615.3 m587.6 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

418.3 m455.8 m446.6 m423 m454.9 m438 m442.2 m483.7 m532.6 m

Cost of goods sold

293 m299.7 m294.4 m301.5 m302.8 m311.8 m318.1 m335.8 m365.2 m

Gross profit

125.3 m156.1 m152.2 m121.5 m152.1 m126.2 m124.1 m147.9 m167.4 m

Gross profit Margin, %

30%34%34%29%33%29%28%31%31%
USDFY, 2014FY, 2015FY, 2016

Cash

74.4 m151.3 m131.6 m

Accounts Receivable

403.7 m372.4 m414.8 m

Inventories

134.8 m132.9 m154.8 m

Current Assets

687.5 m737.5 m790.2 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

63.2 m84.1 m116.1 m151.4 m132.1 m255.8 m241.2 m

Accounts Receivable

332.2 m336.4 m331.6 m308.2 m332 m343.7 m376.3 m366.3 m402.6 m

Inventories

142.4 m144.3 m142.2 m150.9 m159.3 m167.7 m177.5 m169.8 m193.9 m

Current Assets

619.1 m637.5 m653.1 m691.2 m679.5 m727.5 m768.9 m882.6 m928.4 m
USDFY, 2014FY, 2015FY, 2016

Net Income

15.2 m210.3 m111.2 m

Depreciation and Amortization

142.9 m140.8 m140.6 m

Cash From Operating Activities

178.3 m171.8 m155.3 m

Capital Expenditures

122.4 m141 m139.6 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

39.5 m49.3 m4.6 m22 m26 m

Depreciation and Amortization

35 m70.2 m104.6 m35.5 m70.7 m105.5 m35.8 m71.3 m107.8 m

Cash From Operating Activities

96 m199.3 m

Cash From Investing Activities

(44.7 m)(196.4 m)(240.3 m)(33.2 m)(82.5 m)(107.8 m)(114.6 m)(138.5 m)(257 m)
USDY, 2017

Revenue/Employee

57.9 k

Financial Leverage

5.1 x
Show all financial metrics

Catalent Operating Metrics

Catalent's Customers was reported to be 1 k in FY, 2016. Catalent's Backlog was reported to be 827.5 m in FY, 2016
FY, 2015FY, 2016

Backlog

827.6 m827.5 m

Patents Issued

1.1 k

Products

7 k

Customers

1 k
Show all operating metrics

Catalent Market Value History

Catalent Revenue Breakdown

Traffic Overview of Catalent

Catalent Online and Social Media Presence

Catalent News and Updates

Pharmaceutical Sofegel Capsules 2017 Global Industry Sales, Supply, Consumption, Analysis and Forecasts to 2022

Wiseguyreports.Com Publish New Market Research Report On-“Pharmaceutical Sofegel Capsules 2017 Global Industry Sales, Supply, Consumption, Analysis and Forecasts to 2022”. Posted via Industry Today. Follow us on Twitter @IndustryToday

Catalent Company Life and Culture

You may also be interested in